MHConcierge posts for 8-23-21, tech innovations and resources

MHConcierge posts for 8-23-21, tech innovations and resources

How Hushmail Can Help Your Private Therapy Practice Stay Compliant  – this blog post from Brighter Vision reviews email HIPAA risks and the advantages of encrypted email services. FDA OKs Stimulation Device for Anxiety in Depression – the FDA expanded approval for the noninvasive BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMSTM) System to include treatment of comorbid anxiety symptoms in adult patients with depression based on data on 573 patients which “demonstrated a treatment effect that was consistent, robust, and clinically meaningful for decreasing anxiety symptoms in adult patients suffering from major depressive disorder…” From: Medscape.com 4 Key questions to consider

MHConcierge posts for 8-16-21, innovations and research about kids

MHConcierge posts for 8-16-21, innovations and research about kids

Covid-19: Children born during the pandemic score lower on cognitive tests, study finds  A longitudinal study of 672 children from Rhode Island that has run since 2011 had found those born after the pandemic began showed results on the Mullen scales of early learning that corresponded to an average IQ score of 78, a drop of 22 points from the average of previous cohorts. The researchers have largely ruled out a direct effect of the virus, as mothers or children with a history of testing positive for covid-19 were excluded from the analysis. Instead, the authors say, reduced interaction with

MHConcierge posts for 8-9-21, with brief MHConcierge summaries and links to original articles

A study comparing two types of ADHD medications in preschool-age children shows alpha-2-adrenergic agonists like guanfacine and clonidine are effective in reducing ADHD symptoms but with a lower rate of side effects – A study of nearly 500 pediatric treatment records of preschool-age children with ADHD found that about 35% were being treated with A2A medications (including Tenex and Intuniv), even though “little is known about their effectiveness and safety in this age group.  The current study found that A2As are nearly as effective as stimulants but have a lower rate of side effects. One research was quested, “… A2As can